MCQs Quiz

Introduction: Research methodology in B. Pharm focuses on selecting a research topic and formulating a clear hypothesis to drive meaningful pharmaceutical investigations. Choosing the right topic requires assessing relevance to pharmacy practice, literature gaps, feasibility, available resources, ethical considerations, and alignment with career goals. A well-crafted hypothesis—testable, specific, and measurable—guides study design, variable selection, and … Read more

Introduction: Screening models for anti-asthmatic drugs are essential tools for B. Pharm students to understand how candidate compounds affect bronchoconstriction, airway inflammation, and remodeling. These models include in vivo animal models (ovalbumin‑sensitized mice, guinea pig tracheal chain, methacholine or histamine challenge), ex vivo preparations (isolated trachea, lung slices), and in vitro assays (mast cell degranulation, … Read more

Introduction Screening models for anticancer drugs are essential tools B. Pharm students must understand to bridge pharmacology and drug discovery. Key models include in vitro cell lines, 3D spheroids, patient-derived organoids, and in vivo xenografts and genetically engineered mouse models. High-throughput screening (HTS), IC50 determination, mechanism-based cytotoxicity assays, and ADMET profiling enable identification and optimization … Read more

Screening models for antidiabetic drugs are essential in B. Pharm education, linking pharmacology, pharmaceutics and drug discovery. This concise guide reviews in vitro models (beta‑cell lines, adipocytes, hepatocytes), in vivo rodent and genetic models (STZ, alloxan, db/db, ob/ob), and modern high-throughput screening, ADMET evaluation, pharmacodynamics, and toxicity screening. Students will learn key assays — insulin … Read more

Introduction: Screening models for antiulcer drugs are essential in experimental pharmacology for B.Pharm students to understand drug discovery and evaluation. These models—such as pylorus ligation, ethanol-induced, NSAID-induced (indomethacin), acetic acid-induced chronic ulcer, stress-induced and cysteamine-induced duodenal ulcer—help assess antisecretory and cytoprotective actions, ulcer index, gastric acidity, mucosal blood flow, and biomarkers (mucin, GSH, MPO, SOD). … Read more

Screening models for cardiovascular drugs are essential for evaluating antiaggregatory and anticoagulant agents during preclinical and early clinical development. B. Pharm students should understand in vitro and in vivo models—platelet aggregation assays (light transmission aggregometry, whole blood impedance), flow cytometry (P‑selectin), thrombin generation assays, chromogenic anti‑Xa, PT/aPTT, and viscoelastic tests (TEG/ROTEM)—along with animal thrombosis models … Read more

Screening models for cardiovascular drugs – antidyslipidemics covers in vitro, in silico and in vivo approaches used to discover and evaluate lipid‑lowering agents. B. Pharm students should understand HMG‑CoA reductase and CETP enzyme assays, LDL uptake in hepatic cell lines, high‑throughput docking, and animal models like Triton WR‑1339, poloxamer‑407, high‑fat diet, ApoE‑/‑ and LDLr‑/‑ mice. … Read more

Screening models for cardiovascular drugs – antiarrhythmics MCQs With Answer This concise introduction covers screening models for cardiovascular drugs, focusing on antiarrhythmics and translational safety pharmacology for B. Pharm students. You will learn key concepts like ion channel assays (hERG, Nav1.5, Cav1.2), patch‑clamp and automated electrophysiology, hiPSC‑derived cardiomyocytes, MEA and optical mapping, isolated tissue and … Read more

Introduction Screening models for cardiovascular drugs—diuretics MCQs With Answer introduces B. Pharm students to essential experimental and clinical approaches used to evaluate diuretics. This concise guide covers in vitro assays (cell-based transport studies, isolated nephron segments), in vivo animal models (rodent urine-volume and electrolyte excretion tests), key targets (NCC, NKCC2, ENaC), pharmacodynamics, pharmacokinetics, biomarkers, safety … Read more

Screening models for cardiovascular drugs—antihypertensives are vital for B.Pharm students to evaluate drug efficacy, safety, and mechanisms affecting blood pressure. This overview highlights in vitro and in vivo models: isolated tissue preparations (aortic rings, wire myograph, Langendorff heart), cell-based assays (HUVEC, vascular smooth muscle cells), and animal models (SHR, DOCA-salt, two-kidney one-clip). Key terms include … Read more